NEGXF Financials: NexgenRx Inc AI Analysis

Home

Stock

NEGXF

Financials

NEGXF Financial

NexgenRx Inc

0%

$0

At close: Mar 24, 16:00:00 GMT-4

0%

$0

Post-market: Mar 24, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is NEGXF?

NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. The company is headquartered in Toronto, Ontario. The company went IPO on 2006-09-14. The firm administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using proprietary computer software and also providing ancillary services. The company offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys is a fully integrated rules based adjudication platform for secure real-time processing of drug, dental and extended health benefit claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. The NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

NEGXF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	17	16	13	12	11	10
Revenue Growth (YoY)	6%	23%	8%	9%	10%	11%
Cost of Revenue	3	3	3	2	2	1
Gross Profit	14	13	10	10	9	9
Selling, General & Admin	11	10	9	8	6	6
Research & Development	--	--	--	--	--	--
Operating Expenses	12	12	11	10	7	7
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	1	1	0	0	2	1
Income Tax Expense	0	0	0	0	-2	0
Net Income	1	0	0	0	4	2
Net Income Growth	--	--	--	-100%	100%	--
Shares Outstanding (Diluted)	84.25	70.93	70.53	70.33	74.83	69.91
Shares Change (YoY)	10%	1%	0%	-6%	7%	0%
EPS (Diluted)	0.01	0	0	0	0.05	0.03
EPS Growth	425%	-285%	1,467%	-101%	77%	-1,110%
Free Cash Flow	2	0	1	0	3	2
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	82.35%	81.25%	76.92%	83.33%	81.81%	90%
Operating Margin	5.88%	6.25%	0%	0%	18.18%	10%
Profit Margin	5.88%	0%	0%	0%	36.36%	20%
Free Cash Flow Margin	11.76%	0%	7.69%	0%	27.27%	20%
EBITDA	2	2	1	1	3	1
EBITDA Margin	11.76%	12.5%	7.69%	8.33%	27.27%	10%
D&A For EBITDA	1	1	1	1	1	0
EBIT	1	1	0	0	2	1
EBIT Margin	5.88%	6.25%	0%	0%	18.18%	10%
Effective Tax Rate	0%	0%	0%	0%	-100%	0%

Follow-Up Questions

What are NexgenRx Inc's key financial statements?



According to the latest financial statement (Form-10K), NexgenRx Inc has a total asset of $30, Net loss of $0

What are the key financial ratios for NEGXF?



NexgenRx Inc's Current ratio is 1.36, has a Net margin is 0, sales per share of $0.22.

How is NexgenRx Inc's revenue broken down by segment or geography?



NexgenRx Inc largest revenue segment is Administration Fees, at a revenue of 6,361,796 in the most earnings release.For geography, Canada is the primary market for NexgenRx Inc, at a revenue of 13,846,329.

Is NexgenRx Inc profitable?



no, according to the latest financial statements, NexgenRx Inc has a net loss of $0

Does NexgenRx Inc have any liabilities?



yes, NexgenRx Inc has liability of 22

How many outstanding shares for NexgenRx Inc?



NexgenRx Inc has a total outstanding shares of 71.11

NexgenRx Inc (NEGXF) Financial

NEGXF Stock Price Chart